Compare EPR Properties (EPR) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPR Properties vs Heron Therapeutics Inc — how do they compare? EPR Properties trades at $60.2 (market cap $4.58B), while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: EPR Properties is far larger — about 74.5× Heron Therapeutics Inc's market cap, and EPR Properties pays a 6.22% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| EPR | HRTX | |
|---|---|---|
Market Cap | $4.58B | $61.47M |
Sector | Real Estate | Health |
52-Week High | $64.32 | $1.49 |
52-Week Low | $48.71 | $0.32 |
Enterprise Value | $8.09B | $168.21M |
Dividend Yield | 6.22% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
